Moonage Media Review: Viewbix (VBIX) Targets Israel's Multi-Disciplinary Quantum Hub in Strategic Acquisition Move Toward the Quantum Future

Rhea-AI Summary

Viewbix (NASDAQ: VBIX) signed a definitive agreement on Dec 15, 2025 to acquire 85–100% of Israel's Quantum X Labs, subject to due diligence, regulatory approvals and customary closing conditions.

Key milestones: majority stockholder consent on Jan 5, 2026; Schedule 14C filed Jan 15, 2026; amended private placement of ~800k units at ~$1.75 (~$1.4M gross plus up to $1.68M warrant kicker). Quantum X Labs brings patents in quantum error correction and portfolio companies across navigation, timing, security, clinical quantum research and nuclear simulation. Completion expected within 90 days of the definitive agreement date.

Positive

• Acquisition signed to buy 85–100% of Quantum X Labs (Dec 15, 2025)
• Private placement amended: ~$1.4M gross proceeds plus up to $1.68M warrant kicker
• Portfolio includes IP in quantum error correction and multiple near‑term TAMs

Negative

• Transaction completion remains subject to due diligence and regulatory approvals
• Financing size (~$1.4M) is modest relative to typical quantum R&D capital needs
• Closing contingent on customary conditions and Schedule 14C effective timing under Delaware law

Key Figures

Quantum X stake range: 85–100% Private placement units: 800k units Unit price: ~$1.75 +5 more

8 metrics

Quantum X stake range 85–100% Planned acquisition of Quantum X Labs by Viewbix

Private placement units 800k units Amended private placement early January 2026

Unit price ~$1.75 Pricing per unit in private placement

Gross proceeds ~$1.4M Estimated gross from private placement

Warrant kicker up to $1.68M Additional potential proceeds from warrants

Closing window 90 calendar days Expected time to complete acquisition and placement

Definitive agreement date Dec 15, 2025 Execution date for Quantum X Labs acquisition agreement

Effective date offset 20th day Timing after Schedule 14C mailing for actions to be effective

Market Reality Check

Price: $6.28 Vol: Volume 21,900 vs 20-day a...

low vol

$6.28 Last Close

Volume Volume 21,900 vs 20-day average 275,618 (relative volume 0.08x) indicates subdued trading ahead of this article. low

Technical RVSN trades below its 200-day MA of 11.31, down 78.76% from its 52-week high and 71.58% above its 52-week low.

Peers on Argus

Sector peers show mixed moves: CVV appeared on the momentum scanner up 4.87%, wh...

1 Up 1 Down

Sector peers show mixed moves: CVV appeared on the momentum scanner up 4.87%, while KITT was down 5.19%. With RVSN’s own short-term direction flag set to null and no broad, same-direction peer trend, the context points to stock-specific dynamics rather than a clear sector rotation.

Previous Acquisition Reports

2 past events · Latest: Jan 14 (Positive)

Same Type Pattern 2 events

Date	Event	Sentiment	Move	Catalyst
Jan 14	Quantum stake closed	Positive	-8.7%	Completion of 51% Quantum Transportation acquisition using equity and a loan facility.
Dec 01	Quantum deal signed	Positive	-1.9%	Agreement to acquire 51% of Quantum Transportation, pending closing conditions.

Pattern Detected

For acquisition headlines, RVSN has seen negative next-day moves of -8.7% and -1.91%, suggesting a pattern of weak price response to this news type.

Recent Company History

Over the past several months, RVSN has used acquisitions to enter quantum computing for transportation, signing and then closing a deal for a 51% stake in Quantum Transportation. Those acquisition announcements on Dec 1, 2025 and Jan 14, 2026 led to next‑day moves of -1.91% and -8.7%. Today’s article highlights another quantum-focused acquisition in Israel’s ecosystem, indirectly reinforcing the strategic context around RVSN’s existing Quantum Transportation position.

Historical Comparison

-5.3% avg move · In the last two acquisition announcements, RVSN’s stock moved an average of -5.3% the next day, indi...

acquisition

-5.3%

Average Historical Move acquisition

In the last two acquisition announcements, RVSN’s stock moved an average of -5.3% the next day, indicating that past M&A headlines in quantum transportation have not been rewarded with positive short‑term price reactions.

RVSN progressed from signing to closing a 51% Quantum Transportation acquisition, building a foothold in quantum error correction for transportation.

Market Pulse Summary

This announcement highlights Viewbix’s planned acquisition of Quantum X Labs, an Israeli quantum hub...

Analysis

This announcement highlights Viewbix’s planned acquisition of Quantum X Labs, an Israeli quantum hub whose portfolio includes Quantum Transportation, in which RVSN holds a 51% stake. It reinforces the growing quantum ecosystem around transportation, navigation, and security that RVSN has already tapped. Investors may track how these third‑party developments intersect with RVSN’s own quantum error‑correction work, prior acquisition terms, and regulatory filings as they assess longer‑term strategic impact.

Key Terms

schedule 14c, private placement, warrant, provisional patent, +3 more

7 terms

schedule 14c regulatory

"Definitive Schedule 14C filed with the SEC January 15, 2026."

Schedule 14C is an SEC filing that companies use to send an official information statement to shareholders when they are not asking for proxy votes. It lays out key facts about corporate actions—such as reorganizations, related-party transactions, or changes in governance—so investors can understand what’s happening without being asked to vote, like receiving a detailed neighborhood notice about a rule change rather than a petition. Because it provides formal, regulated disclosure, Schedule 14C helps investors verify claims, weigh potential impacts on ownership or value, and hold management accountable.

private placement financial

"Private placement financing amended early January (800k units at ~$1.75..."

A private placement is a way for companies to raise money by selling securities directly to a small group of investors instead of through a public offering. This process is often quicker and less regulated, making it similar to offering a special, exclusive investment opportunity to select individuals or institutions. For investors, it can provide access to unique investment options that are not available on public markets.

warrant financial

"... ~$1.4M gross + up to $1.68M warrant kicker)."

A warrant is a time-limited financial contract that gives its holder the right to buy a company's shares at a set price before a specified date, like a coupon that lets you purchase stock at a fixed discount for a limited time. It matters to investors because warrants offer leveraged exposure to a stock’s upside and can dilute existing shareholders if exercised, so they affect potential gains and the company’s outstanding share count.

provisional patent regulatory

"...including a recent provisional patent for quantum-enhanced Markov Chain Monte Carlo methods..."

A provisional patent is a temporary filing that locks in an early priority date for an invention and lets a company label the technology as "patent pending" while it develops the idea and prepares a full patent application. It matters to investors because it signals an intent to protect intellectual property with relatively low initial cost and a limited window to convert to a full patent; it can reduce the risk of being preempted by others but does not guarantee long-term legal protection.

markov chain monte carlo medical

"....provisional patent for quantum-enhanced Markov Chain Monte Carlo methods..."

A Markov Chain Monte Carlo (MCMC) method is a way to simulate many possible outcomes from a complex probability model by taking a sequence of random steps that gradually explores the most likely scenarios, like a hiker using many short, guided walks to map an unexplored landscape. For investors it matters because MCMC helps quantify uncertainty and estimate probabilities for pricing, risk, and forecasts when formulas are too complex to solve directly, improving decisions under uncertainty.

quantum error correction technical

"....including prior IP in quantum error correction."

Quantum error correction is a set of methods for detecting and fixing mistakes in quantum computers by encoding fragile quantum information across multiple physical parts, much like using multiple copies or checksums to protect a sensitive digital file. For investors, it matters because reliable error correction is a key technical milestone that determines whether quantum machines can scale from experimental devices to practical tools that could disrupt computing, encryption, drug discovery and other industries.

definitive agreement regulatory

"Viewbix recently signed a definitive agreement to acquire up to 100%..."

A definitive agreement is a formal, legally binding document that outlines the final terms and conditions of a deal or transaction, such as a sale or partnership. It acts like a detailed contract that confirms all parties have agreed on the key details, making the deal official. For investors, it signals that the agreement is settled and moving toward completion, providing clarity and security about the transaction.

AI-generated analysis. Not financial advice.

HONG KONG, Feb. 23, 2026 /PRNewswire/ -- Viewbix Inc. (NASDAQ: VBIX), an advanced technologies company, in mid-December 2025, signed a definitive agreement to acquire 85–100% of Israel's Quantum X Labs.

Recent milestones that have been achieved include:

• Majority stockholder written consent secured January 5, 2026.
• Definitive Schedule 14C filed with the SEC January 15, 2026.
• Private placement financing amended early January (800k units at ~$1.75, ~$1.4M gross + up to $1.68M warrant kicker).

Completion of the acquisition and the private placement is expected to occur within 90 calendar days of the date of the definitive agreement, which remains subject to final due diligence, regulatory approvals and customary closing conditions..

But the real fuel is what's happening inside Quantum X Labs' portfolio companies:

• Quantum Gyro: Developing quantum gyroscope technology that is reliable for GPS-denied environments, essential for defense, autonomous vehicles, and remote operations.
• Quantum Transportation: Addressing scalability issues in quantum computing with patented solution (QECC) that reduce quantum computational noises. The Company already started working with Rail Vision Ltd. (Nasdaq: RVSN), which acquired 51% of Quantum Transportation in January 2026, on harnessing quantum computing and reducing errors in big data analysis and major transportation platforms.
• Cliniquantum: Focused on clinical and biomedical research, including a recent provisional patent for quantum-enhanced Markov Chain Monte Carlo methods that could revolutionize drug discovery by uncovering hidden biological structures in trial data.
• Quantum Aton Accuracy: Leveraging quantum principles for unprecedented precision in timing and synchronization applications.
• QuantumQ Security: Protecting data, communications, and critical infrastructure against emerging threats.
• Nuclear Quantum- Working on the development of breakthrough applications where quantum computing eliminates the fundamentals bottlenecks in reactor simulation, safety verification and materials science.

Quantum X Labs offers exposure to quantum's biggest near-term TAMs: navigation, precision timing, security, error correction, nuclear simulation. Israel's elite university ecosystem (Hebrew U, TAU, Technion, Weizmann) supplies the talent edge, and the Denmark quantum conference showcase last fall already introduced them to the market.

Founded on the vision that quantum progress thrives through interdisciplinary convergence, Quantum X Labs has built a unique ecosystem uniting top-tier talent and cutting-edge research. Drawing from Israel's renowned academic powerhouses- including the Hebrew University of Jerusalem, Tel Aviv University, the Technion, and the Weizmann Institute- Quantum X Labs employs a multidisciplinary team of scientists, engineers, and researchers. This blend of theoretical expertise and practical engineering has enabled rapid translation of ideas into deployable technologies, positioning Quantum X Labs as a player in Israel's quantum sector.

Viewbix recently signed a definitive agreement to acquire up to 100% (and not less than 85%) of Quantum X Labs (the "Acquisition"), encompassing its expanding patent portfolio, including prior IP in quantum error correction. The acquisition is expected to close within 90 days of the date of execution of the definitive agreement, which was December 15, 2025, subject to final due diligence, regulatory approvals, and customary closing conditions. On January 5, 2026, Viewbix announced that it had received the requisite stockholder approval via written consent of the majority of its stockholders (the "Stockholder Consent") and on January 15, 2026, Viewbix filed a definitive information statement on Schedule 14C with the Securities and Exchange Commission. Pursuant to Delaware Law, the actions to be taken pursuant to the Stockholder Consent shall be effective on the 20th day after the definitive information statement on Schedule 14C is mailed or furnished to Viewbix's stockholders.

Paid Promotional Disclosure

This press release constitutes a paid promotional communication. Viewbix has engaged a third-party service provider to provide investor awareness and promotional services, including the dissemination of this press release, and has paid a fee for such services. Viewbix exercises editorial control over the content of this press release but does not control how, when, or to whom the information is distributed by such third party.

This press release is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any securities of Viewbix. Investing in Viewbix's securities involves significant risks, and readers are encouraged to review Viewbix's filings with the U.S. Securities and Exchange Commission available at www.sec.gov before making any investment decision.

Moonage Media Disclaimer

This article was produced by Moonage Media, a brand / division of MR Solutions Limited (Hong Kong), and is provided for general informational and promotional purposes only. The content does not constitute investment advice, financial advice, medical advice, or a recommendation to buy, sell, or hold any securities, nor does it constitute an offer or solicitation in any jurisdiction.

Moonage Media is not a registered broker-dealer, investment adviser, securities analyst, or medical professional. The information presented is based on publicly available sources and statements believed to be reliable at the time of publication; however, Moonage Media makes no representations or warranties as to the accuracy or completeness of the information and has not independently verified all data referenced.

Certain content published by Moonage Media may be sponsored or compensated by the company discussed or its affiliates, which may create a potential conflict of interest. Readers are encouraged to conduct their own independent research and consult qualified financial, legal, medical, or other professional advisers before making any investment or health-related decisions.

Forward-looking statements referenced in this article are subject to risks and uncertainties, and actual results may differ materially. Past performance is not indicative of future results.

For full disclosures, risk factors, and forward-looking statements, please visit:
https://moonage.media/disclaimer/

Contact:

Moonage Media

Office@Moonage.media

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Words such as "expects," "anticipates," "intends," "plans," "believes," "seeks," "estimates" and similar expressions or variations of such words are intended to identify forward-looking statements. For example, forward-looking statements in this press release include the timing and completion of the acquisition and the private placement, the receipt of regulatory approvals, the satisfaction of closing conditions related to the acquisition and positioning Quantum X Labs as a player in Israel's quantum sector. Because such statements deal with future events and are based on Viewbix's current expectations, they are subject to various risks and uncertainties, and actual results, performance or achievements could differ materially from those described in or implied by the statements in this press release.

The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, including those discussed in any filings with the SEC. Except as otherwise required by law, Viewbix undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. Viewbix is not responsible for the contents of third-party websites.

View original content:https://www.prnewswire.com/news-releases/moonage-media-review-viewbix-vbix-targets-israels-multi-disciplinary-quantum-hub-in-strategic-acquisition-move-toward-the-quantum-future-302694619.html

SOURCE Moonage Media

FAQ

What did Viewbix (VBIX) announce about acquiring Quantum X Labs on Dec 15, 2025?

Viewbix announced a definitive agreement to acquire 85–100% of Quantum X Labs, aiming to close within 90 days. According to the company, the deal is subject to final due diligence, regulatory approvals and customary closing conditions, with stockholder consent secured on Jan 5, 2026.

How was the Viewbix (VBIX) acquisition of Quantum X Labs financed?

Financing was amended to include ~800k units at about $1.75, roughly $1.4M gross and up to $1.68M warrant kicker. According to the company, those terms accompany the acquisition and are part of the private placement amended in early January 2026.

What strategic assets does Quantum X Labs bring to Viewbix (VBIX)?

Quantum X Labs brings patents including prior IP in quantum error correction and multiple applied-quantum initiatives. According to the company, portfolio firms target navigation, precision timing, security, error correction, nuclear simulation and clinical quantum methods.

How does Rail Vision (RVSN) relate to the Quantum X Labs transaction in January 2026?

Rail Vision (RVSN) acquired 51% of Quantum Transportation, a Quantum X Labs portfolio company, in January 2026. According to the company, Viewbix is working with RVSN on harnessing quantum computing to reduce errors in big data and transportation platforms.

What are the main completion risks for Viewbix's (VBIX) acquisition of Quantum X Labs?

The main risks are final due diligence, regulatory approvals and customary closing conditions that could delay or alter the deal. According to the company, the acquisition remains conditional and is expected to close only after those steps are satisfied.